QRISK3与SCORE联合预测类风湿关节炎患者颈动脉斑块
该研究纳入865例无糖尿病、慢性肾病或心血管事件史的RA患者,2012–2019年间行颈动脉超声,回顾性评估QRISK3与EULAR mSCORE单独及联合识别颈动脉斑块的能力。结果显示54%患者存在斑块,两工具联合可识别多数高危斑块患者。
要点
- QRISK3≥10%且EULAR mSCORE<5%组中73.2%存在斑块,诊断OR为5.79。
- 两工具均高于高危阈值时敏感性升至83.3%,诊断OR达10.6。
- 两评分连续变量每增加1%,斑块概率分别乘以1.14和1.22。
核心结论
- QRISK3与EULAR mSCORE联合使用可识别大多数颈动脉斑块高风险的RA患者。
研究设计与样本
- 基于人群的RA起始队列中,连续纳入865例无糖尿病、慢性肾病或心血管事件史的患者,2012–2019年间行颈动脉超声,回顾性测试QRISK3与EULAR mSCORE。
主要发现
- 865例中466例(54%)存在颈动脉斑块。
- QRISK3≥10%且EULAR mSCORE<5%的患者中73.2%(95%CI:68.4.8,77.6)有斑块,诊断OR为5.79(95%CI:4.14,8.10)。
- QRISK3≥10%且EULAR mSCORE≥5%时敏感性83.3%(95%CI:72.1,91.4),诊断OR为10.6(95%CI:5.13,22.0)。
- QRISK3或EULAR mSCORE每增加1%,斑块概率分别乘以1.14和1.22,但两算法效应无相乘交互。
关键数值与推荐
- QRISK3高危阈值≥10%,EULAR mSCORE高危阈值≥5%。
- QRISK3≥10%且EULAR mSCORE<5%组斑块患病率73.2%,诊断OR 5.79。
- 两工具均≥高危阈值时敏感性83.3%,诊断OR 10.6。
临床怎么用
- 对无糖尿病、慢性肾病或心血管事件史的RA患者,可联合QRISK3与EULAR mSCORE评估颈动脉斑块风险。
- QRISK3≥10%且EULAR mSCORE<5%的患者仍应关注斑块风险,因该组斑块患病率达73.2%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Because carotid plaques predict the development of cardiovascular events in RA, we aimed to assess if the combined use of the systematic coronary risk evaluation (SCORE) and the QRISK3 algorithms allows for the identification of RA patients with carotid plaques in a defined population-based RA inception cohort. METHODS: A set of consecutive RA patients without a history of diabetes, chronic kidney disease or cardiovascular events were studied by carotid US between 2012 and 2019. Modified SCORE (mSCORE) for RA based on the 2015/2016 updated EULAR recommendations and QRISK3 algorithms were retrospectively tested using baseline data obtained at the time of the carotid US assessment. RESULTS: A total of 466 (54%) of 865 patients had carotid plaques. Using dichotomized QRISK3 and EULAR mSCORE, 73.2% (95% CI: 68.4.8, 77.6) of patients with QRISK ≥ 10% and EULAR mSCORE < 5% had plaque. In this group, the diagnostic odds ratio was 5.79 (95% CI: 4.14, 8.10). However, if both algorithms were above their thresholds of high cardiovascular risk (QRISK ≥ 10% and EULAR mSCORE ≥ 5%), the sensitivity increased up to 83.3% (95% CI: 72.1, 91.4) and the diagnostic odds ratio up to 10.6 (95% CI: 5.13, 22.0). When the risk charts scales were used as continuous variables, both QRISK3 and EULAR mSCORE were found positively associated with plaque. For each 1% QRISK3 or EULAR mSCORE increase, the probability of having plaques multiplied by 1.14 and 1.22, respectively. However, the effects of both algorithms did not multiply by each other. CONCLUSIONS: . The combined use of QRISK3 and EULAR mSCORE allows for the identification of most RA patients at high risk of carotid plaques.
引用
- Corrales A, Vegas-Revenga N, Atienza-Mateo B, et al. Combined use of QRISK3 and SCORE as predictors of carotid plaques in patients with rheumatoid arthritis. Rheumatology (Oxford). 2021. PMID: 33249513. doi:10.1093/rheumatology/keaa718
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。